These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 19161877)
1. Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy. Reffelmann T; Könemann S; Kloner RA J Am Coll Cardiol; 2009 Jan; 53(4):305-8. PubMed ID: 19161877 [TBL] [Abstract][Full Text] [Related]
2. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy. Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs. Li SR; Qi XY; Hu FL; Zhang JQ; Wang TH; Dang Y; Meng CL; Liu HL; Li YX; Wu D; Dong J; Xun LY; Gao LH; Jin FC Chin Med J (Engl); 2008 Dec; 121(23):2403-9. PubMed ID: 19102957 [TBL] [Abstract][Full Text] [Related]
4. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging. Traverse JH; Henry TD; Moye' LA Am Heart J; 2011 Oct; 162(4):671-7. PubMed ID: 21982659 [TBL] [Abstract][Full Text] [Related]
6. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ; Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649 [TBL] [Abstract][Full Text] [Related]
7. Intracoronary blood- or bone marrow-derived cell transplantation in patients with ischemic heart disease. Reffelmann T; Kloner RA Regen Med; 2009 Sep; 4(5):709-19. PubMed ID: 19761396 [TBL] [Abstract][Full Text] [Related]
8. [Experiences with the first, Hungarian autologous bone marrow cell transplantation in acute myocardial infarction]. Vértesaljai M; Piróth Z; Fontos G; Tóth A; Simor T; Lueff S; Reményi P; Réti M; Masszi T; Andréka P Orv Hetil; 2006 Jan; 147(1):3-6. PubMed ID: 16519064 [TBL] [Abstract][Full Text] [Related]
9. Intracoronary autologous bone marrow stem cells transfer for patients with acute myocardial infarction: a meta-analysis of randomised controlled trials. Zhang SN; Sun AJ; Ge JB; Yao K; Huang ZY; Wang KQ; Zou YZ Int J Cardiol; 2009 Aug; 136(2):178-85. PubMed ID: 18644638 [TBL] [Abstract][Full Text] [Related]
10. Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction. Plewka M; Krzemińska-Pakuła M; Lipiec P; Peruga JZ; Jezewski T; Kidawa M; Wierzbowska-Drabik K; Korycka A; Robak T; Kasprzak JD Am J Cardiol; 2009 Nov; 104(10):1336-42. PubMed ID: 19892047 [TBL] [Abstract][Full Text] [Related]
11. Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study. Beitnes JO; Hopp E; Lunde K; Solheim S; Arnesen H; Brinchmann JE; Forfang K; Aakhus S Heart; 2009 Dec; 95(24):1983-9. PubMed ID: 19833610 [TBL] [Abstract][Full Text] [Related]
12. Cellular transplantation: future therapeutic options. Allan R; Kass M; Glover C; Haddad H Curr Opin Cardiol; 2007 Mar; 22(2):104-10. PubMed ID: 17284988 [TBL] [Abstract][Full Text] [Related]
13. Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction. Mathieu M; Bartunek J; El Oumeiri B; Touihri K; Hadad I; Thoma P; Metens T; da Costa AM; Mahmoudabady M; Egrise D; Blocklet D; Mazouz N; Naeije R; Heyndrickx G; McEntee K J Thorac Cardiovasc Surg; 2009 Sep; 138(3):646-53. PubMed ID: 19698851 [TBL] [Abstract][Full Text] [Related]
16. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Seeger FH; Tonn T; Krzossok N; Zeiher AM; Dimmeler S Eur Heart J; 2007 Mar; 28(6):766-72. PubMed ID: 17298974 [TBL] [Abstract][Full Text] [Related]
17. Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells. Zenovich AG; Davis BH; Taylor DA Handb Exp Pharmacol; 2007; (180):117-65. PubMed ID: 17554507 [TBL] [Abstract][Full Text] [Related]
18. Role of stem and progenitor cells in postmyocardial infarction patients. Liu X; Dauwe D; Patel A; Janssens S Minerva Cardioangiol; 2009 Apr; 57(2):219-31. PubMed ID: 19274031 [TBL] [Abstract][Full Text] [Related]
19. Clinical trials using autologous bone marrow and peripheral blood-derived progenitor cells in patients with acute myocardial infarction. Tendera M; Wojakowski W Folia Histochem Cytobiol; 2005; 43(4):233-5. PubMed ID: 16382891 [TBL] [Abstract][Full Text] [Related]
20. [Current practice and future perspectives of myocardial stem cell therapy]. Balogh L; Czuriga I; Kristóf E; Edes I Orv Hetil; 2005 May; 146(20 Suppl 2):1110-20. PubMed ID: 15945240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]